Lares-Asseff I.
137
Coauthors
9
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Genética | 9 |
| Farmacología | 7 |
| Pediatría | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 7 |
| Enfermedades | 5 |
| Ginecología, obstetricia, pediatría, geriatría | 3 |
| Bioquímica | 3 |
| Salud y seguridad personal | 2 |
| Cultura e instituciones | 1 |
| Fisiología humana | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 9 |
| RRAAE | 1 |
| Google Scholar | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Sosa-Macías M.G. | 7 |
| Fausto Zaruma-Torres | 5 |
| Galaviz-Hernandez C. | 4 |
| Adrián LLerena | 4 |
| Dorado P. | 4 |
| Loera-Castañeda V. | 3 |
| Reyes-Espinoza A. | 3 |
| Penãs-Lledó E.M. | 3 |
| Almanza-Reyes H. | 2 |
| Alanis-Bãuelos R.E. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Pharmacogenomic studies in Mexico, central America and Cuba in amerindians groups: Clinical applications and toxicology
Book PartAbstract: In Latin America, the first study focused on the pharmacogenetics of CYP2D6 was developed in 1986 byPalabras claves:Clinical pharmacology, Clinician toxicology, Latin America, pharmacogenetics, PharmacogenomicsAutores:Bailón-Soto C., Fausto Zaruma-Torres, Lares-Asseff I.Fuentes:scopusInfluence of CYP2D6 deletion, multiplication, -1584C→G, 31G→A and 2988G→A gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos
ArticleAbstract: The aim of this study was to explain the variability of CYP2D6 activity by the identification of CYPPalabras claves:allele frequency, CYP2D6 polymorphism, Dextromethorphan metabolism, Mexican TepehuanosAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Sosa-Macías M.G.Fuentes:scopusImpact of genetic polymorphism of metabolic pathway of methotrexate and survival rate of Mexican children will all
ArticleAbstract: Background: Acute lymphoblastic leukemia (ALL) is a major cancer disease in Mexican pediatric populaPalabras claves:Atp-Binding Cassette Transporter Gene, Fpgs, Genetic Polymorphisms, methotrexate, Precursor cell lymphoblastic leukemia-lymphoma/*drug therapy/genetics, Survival, XOAutores:Almanza-Reyes H., Fausto Zaruma-Torres, Lares-Asseff I., Loera-Castañeda V., María Cristina Arias-Peláez, Reyes-Espinoza A.Fuentes:scopusAssociation of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL
ArticleAbstract: Background: Acute lymphoblastic leukemia (ALL) is one of the most frequent oncological disorders inPalabras claves:Atp-Binding Cassette Transporter Gene, drug therapy/genetics, Genetic Polymorphisms, methotrexate, pharmacovigilance, precursor cell lymphoblastic leukemia-lymphoma/, xanthine oxidase (XO)Autores:Almanza-Reyes H., Chairez-Hernández I., Fausto Zaruma-Torres, Galaviz-Hernandez C., Lares-Asseff I., Loera-Castañeda V., Reyes-Espinoza A., Sosa-Macías M.G.Fuentes:rraaescopusCYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards
ArticleAbstract: Earlier we had found that the CYP2C9*2 allelic frequency was lower in Mexican-Americans living in CaPalabras claves:CYP2C9, Hispanics, Mexican-Americans, Mexican-Mestizos, Mexican-Tepehuanos, pharmacogeneticsAutores:Adrián LLerena, Alanis-Bãuelos R.E., Dorado P., Lares-Asseff I., Licinio J., Penãs-Lledó E.M., Sosa-Macías M.G., Wong M.L.Fuentes:scopus